This protocol is judged by an institutional evaluation board, an independent team that opinions any clinical trials involving human beings. If a review involves a Agenda I drug, once the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) range in the FDA.Medicines may have not know